Objective Most cerebrovascular disturbances in Behcet's syndrome are occlusive in nature, while hemorrhage is rare.
Introduction
Behcet's syndrome, a multiple-system disease first described in 1937 by the Turkish dermatologist Hulusi Behcet (1) , occurs with a high prevalence in Japan, and in Mediterranean and Middle Eastern countries. Clinically, it is characterized by uveitis, oral aphthae, genital ulcers, and skin lesions, although gastrointestinal, articular, pulmonary, and neurological lesions can also develop. Central nervous system (CNS) involvement has been reported in 10% to 49% of cases (2, 3) and was characterized by meningoencephalitis, benign intracranial hypertension, headaches, seizures, cerebral vessel thrombosis, and vasculitis (4, 5) . Five percent of Behcet's syndrome patients were found to develop mucocutaneous lesions only after the appearance of CNSlesions (6) . Vascular lesions are commonin manyof the complications of Behcet's syndrome. Most of these lesions are thought to contribute to the occlusive process or to aneurysmformation in large vessels (7) . Most cerebrovascular disturbances in Behcet's syndromeare occlusive in nature such as in dural sinus thrombosis (5), while hemorrhage is rare. In this paper, we report three cases of neuro-Behcet's syndromepresenting with intracerebral hemorrhaging, and discuss the possible causes as they relate to cyclosporine treatment.
Case Reports
Patient 1 A 49-year-old man with recurrent uveitis and oral aphthae was diagnosed with Behcet's syndrome and had been taking cyclosporine for more than 5 years. He developed a headache and fever, followed three days later by the appearance of a genital ulcer. A week later, he was admitted to our hospital, complaining of difficulty walking. Neurologic examination revealed right ptosis, weakness of the left orbicularis oculi muscle, generalized hyperreflexia with pathologic reflexes, and mild truncal ataxia. Cerebrospinal fluid (CSF) showed 4 cells/mm3 and 45 mg/dl of protein. A brain computed tomography (CT) scan taken on admission ( Fig. 1) showed a high-density area in the mid-pons consistent with a pontine hemorrhage. An MRI revealed small scattered lesions, enhanced by gadolinium, in the bilateral frontal, parietal, and temporal lobes, supporting a diagnosis of neuroBehcet's syndrome.
Patient 2
A 30-year-old man who had suffered from recurrent uveitis and genital ulcers for 2 years, was admitted to our hospital with left leg weakness. Initial examination revealed an absence of mucocutaneous lesions and uveitis. Neurological examination of this patient, whohad not been taking cyclosporine, showed restricted left eye adduction, mild left hemiparesis with Babinski's sign, and left limb and truncal ataxia. Examination of the CSF revealed pleocytosis (90 cells/mm3; 63% segmentednuclear and 37%mononuclear cells) and a protein concentra- A brain CTscan a day after admission showedabnormal enhancement at the bilateral genu of the internal capsule without any signs of hemorrhage. The patient was treated with corticosteroids and his symptoms gradually improved. Seven weeks later, follow-up MRI detected bilateral low intensities on T2WIin basal ganglionic regions, suggesting post-hemorrhagic hemosiderin deposition (Fig. 2) .
Patient 3
A 48-year-old man had uveitis consistent with Behcet's syndrome for which he was treated with colchicine. A month after developing a high fever and genital ulcer, he was admitted to our hospital complaining of drowsiness. The initial MRIon admission showed a large area of high signal intensity in the right basal ganglia. Four days later, the patient complained of severe abdominal pain necessitating emergency surgery, which revealed multiple ulcers in the ileum and colon. The patient madea moderaterecovery after steroid treatment. In a followup MRIover two weeks later, a low signal intensity on T2WI suggesting the presence of a hemorrhagic lesion was detected at the margin of a large high signal intensity area in the head of the right caudate (Fig. 3) . syndromeresulted in the developmentof inflammatorylesions in the brainstemas well as in a breakdown in the blood-brain barrier (8, 9) . Neuropathologically, the syndromehas been describedas representinga vasculitis withcellular infiltrates mainly affecting postcapillary venules ( 10) , with reports of intracranial hemorrhagesbeing rare. The CTand MRIfindings in our cases indicated the presence of hemorrhages. Onepatient hada massivehemorrhage at the mid-pontinelevel, andthe other twosuggestedsmall hemorrhagesin the basal ganglia and caudatenucleus. The pontinehemorrhage wasidentified at the onset of neurological symptoms, whilethe hemorrhages in the other twocases were thought to be in the subacutephase during the course of treatmentas indicated by the precipitation of hemosiderin. There have been 5 previous reports of neuro-Behc.et's syndromepresenting with intracranial hemorrhage,as determined by CTscan and/or MRI (Table 1) . Takentogether with our data, it appearsthat neuro-Behget'ssyndrome patients canbe dividedinto twogroups: those withhemorrhages in the center of their lesion identified during the acute phase of their illness andthose with hemorrhagesat the periphery of their lesion identified during their subacute phase. Our patients ' histories and laboratory findings suggested that it wasunlikely that the described hemorrhagesdevelopedas a result of hypertension,a vascularanomaly, or a coagulation abnormality. Bleedingof a cryptic angiomawasalso unlikely since it is characterized by heterogenousintensities with heterogenousenhancement on CTscan and/orMRI.Similarly, venousthrombosis wasruled out sinceour patients' sinuses werepatent andsince these patients did not have any coagulation problems. Particularly in the case of the basal ganglia, the hemorrhages werethoughtto be causedbythe vasculitic changesassociated withBehget'ssyndrome, since they appearedat the samesite as the inflammatorylesion in the acute phaseof the disease. It is conceivablethat the massivepontinehemorrhage described in our first case could havebeen inducedbythe vascular changesassociated with Behget's disease, as previously suggested by pathological studies showingsmall hemorrhagic changes resulting from disruption of the integrity of small vessels in this syndrome(ll). A recent report suggestedthat cyclosporine might also be implicated in the developmentof neuro-Behget's syndrome ( 12) . Cyclosporine is knownto damage endothelial cells and to induce reversible ischemiaresulting in "reversible posterior leukoencephalopathy" (13) . It is possiblethat cyclosporine-induceddamage of endothelial cells contributed to the developmentof the hemorrhagiclesion in this patient. However, several studies that reported cerebral hemorrhage in patients takingcyclosporinealso reportedhypertension in these patients (14) , a finding that wasnot observed in the present patient. Theforegoing notwithstanding, the administrationof cyclosporinemightinfluencethe timing andsize of a hemorrhage as well as the courseandseverity of neurological symptoms. It should be noted that Hasegawa et al reported the case of a cyclosporine-treated patient whopresented with an acute, massivehemorrhagein the pons (15) . It is possible that the vascular pathologies caused by Behget's syndromeand by cyclosporine conspire to induce CNShemorrhaging in these patients. Approximately 5%of Behget'ssyndromepatients do not developmucocutaneous manifestationsevenafter neurologic involvement (16) . Thus, it is important to consider neuro-Behcet's syndromeas a diagnosis in patients with intracerebral hemorrhages in general, and in patients with an acute pontine hemorrhage in particular.
